Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Current Oncology (Toronto, Ont.)
|
June 24, 2011
Models of care for early-stage breast cancer in Canada
Y Madarnas, A A Joy, S Verma, et al.
Current Oncology (Toronto, Ont.)
|
June 20, 2015
Third-party online surveys-science, selling, or sugging?
S Mazzarello, M Clemons, I D Graham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2008
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
M H Cullen, P Zatloukal, S Sörenson, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Physician "out of office" alert: does it work?
M Clemons, A A Joy, J Hilton, et al.
Current Oncology (Toronto, Ont.)
|
February 17, 2015
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer
S Chia, S Gandhi, A A Joy, et al.
Current Oncology (Toronto, Ont.)
|
August 17, 2018
Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
N LeVasseur, C Stober, M Ibrahim, et al.
Current Oncology (Toronto, Ont.)
|
March 7, 2018
Alberta CancerBridges development of a care plan evaluation measure
J Giese-Davis, J Sisler, L Zhong, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2014
Qualitative evaluation of care plans for Canadian breast and head-and-neck cancer survivors
K Collie, J McCormick, A Waller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 23, 2018
Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study
R Fernandes, S Mazzarello, A A Joy, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
H S Rugo, R S Finn, V Diéras, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Current Oncology (Toronto, Ont.)
|
June 24, 2011
Models of care for early-stage breast cancer in Canada
Y Madarnas, A A Joy, S Verma, et al.
Current Oncology (Toronto, Ont.)
|
June 20, 2015
Third-party online surveys-science, selling, or sugging?
S Mazzarello, M Clemons, I D Graham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2008
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
M H Cullen, P Zatloukal, S Sörenson, et al.
Current Oncology (Toronto, Ont.)
|
July 7, 2017
Physician "out of office" alert: does it work?
M Clemons, A A Joy, J Hilton, et al.
Current Oncology (Toronto, Ont.)
|
February 17, 2015
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer
S Chia, S Gandhi, A A Joy, et al.
Current Oncology (Toronto, Ont.)
|
August 17, 2018
Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey
N LeVasseur, C Stober, M Ibrahim, et al.
Current Oncology (Toronto, Ont.)
|
March 7, 2018
Alberta CancerBridges development of a care plan evaluation measure
J Giese-Davis, J Sisler, L Zhong, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2014
Qualitative evaluation of care plans for Canadian breast and head-and-neck cancer survivors
K Collie, J McCormick, A Waller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 23, 2018
Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study
R Fernandes, S Mazzarello, A A Joy, et al.
Breast Cancer Research and Treatment
|
January 12, 2019
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
H S Rugo, R S Finn, V Diéras, et al.
Page
of 3